Research on remote exercise support for esophageal cancer patients

Phase 2

Recruiting

• Conditions: Esophageal cancer; Esophageal Neoplasms; D004938

• Registration Number: JPRN-jRCT1062220049
• Lead Sponsor: oma Tomohiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Patients diagnosed with esophageal cancer cStage 1-4a (Union for International Cancer Control criteria) and undergoing preoperative chemotherapy
Male and female patients aged 20 years or older and 80 years or younger at the time of consent.
Two courses of three drugs (docetaxel, cisplatin, and fluorouracil) will be administered as neoadjuvant chemotherapy.

Exclusion Criteria

Diagnosed with dementia
Needs assistance in walking or moving around.
Patients undergoing treatment other than chemotherapy such as radiation therapy
Patients who are judged to be inappropriate as research subjects by the principal investigator and research coordinators.
Patients who are prohibited from exercise therapy by the attending physician due to complications such as serious cardiac or renal disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
6-minute walking distance

Secondary Outcome Measures

Name	Time	Method
ower limb muscle strength<br>Respiratory muscle strength<br>Muscle mass<br>Extracellular water ratio<br>Ability to perform activities of daily living<br>Quality of life<br>Physical activity<br>Malnutrition<br>Adherence<br>adverse events<br>Post-operative indicators<br>Postoperative complications